A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) seem to have little or no effect on obesity-related cancers, according ...

INDIANAPOLIS (WISH) — Cancers in younger adults are surging. Colon cancer, once a midlife disease, is striking earlier than ...

AI-Driven Risk Prediction for Breast, Prostate and Pancreatic CancersTOKYO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- A.D.A.M.

A hidden cancer is striking a new generation. The little-known disease, and warning signs you shouldn't ignore.

A new review of nearly 100,000 participants suggests that glucagon-like peptide-1 receptor agonists (GLP-1RAs), popular ...

Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...

With ESPN set to release a 30 for 30 about Stuart Scott’s legacy, the broadcaster’s friends reflect on what Scott meant, and ...

A new study from researchers at Cambridge, Mass.-based Harvard University found that blockbuster GLP-1 drugs such as Ozempic and Zepbound may have a minimal effect on an individual’s risk of ...

While vitamin C is essential for health, high doses can cause serious side effects. Learn the risks and how to use it safely, ...

Clostridium perfringens, which causes stomach cramps and diarrhoea, was found to be the cause of the outbreak.